Rita Kramer to Breast Neoplasms
This is a "connection" page, showing publications Rita Kramer has written about Breast Neoplasms.
Connection Strength
1.038
-
Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy. FASEB J. 2015 Nov; 29(11):4461-72.
Score: 0.257
-
The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol. 2007 Apr; 30(2):126-32.
Score: 0.145
-
Reproductive issues for women with BRCA mutations. J Natl Cancer Inst Monogr. 2005; (34):83-6.
Score: 0.124
-
26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on clinical research. Breast Cancer Res. 2004; 6(2):84-7.
Score: 0.116
-
Should tamoxifen be used in breast cancer prevention? Drug Saf. 2004; 27(13):979-89.
Score: 0.116
-
BMI, physical activity, and breast cancer subtype in white, black, and Sea Island breast cancer survivors. Adv Cancer Res. 2020; 146:83-102.
Score: 0.089
-
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019 Feb; 173(3):559-571.
Score: 0.081
-
The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer. Breast Cancer Res Treat. 2009 Nov; 118(2):369-75.
Score: 0.042
-
Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer. 2006 Aug 15; 107(4):696-704.
Score: 0.035
-
The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause. J Support Oncol. 2006 Jun; 4(6):295-8, 304.
Score: 0.034